Transplant News and Research

RSS

Study finds gender differences in active medical treatment

New research from the University of St Andrews has found that women are less like than men with the same medical condition to be offered active management such as surgery, a stent or a strong painkiller.

16 Sep 2026

Study raises questions about AI's role in decision support for ethically sensitive situations

Artificial intelligence (AI) models prioritize starkly different attributes than humans when making high-stakes decisions, and they don't express indecision like humans do, according to a new study led by Penn State researchers, raising questions about the role of AI in decision support for ethically sensitive situations like medical decisions.

15 Sep 2026

New treatment option approved in Japan for rare genetic liver disorders

A new indication for an existing drug has been approved in Japan to treat patients with progressive familial intrahepatic cholestasis (PFIC) types 1 and 2, a group of rare genetic liver disorders.

15 Sep 2026

Innovative device improves real-time monitoring of donated lungs

More than three-quarters of donated lungs offered for transplantation are not used, according to the UK's National Institute for Health and Care Excellence, contributing to a chronic shortage of organs for patients with end-stage lung disease.

10 Sep 2026

JMIR Publications: Emerging health tech trends

JMIR Publications released three feature News and Perspectives articles this week, covering an emerging application of drone delivery, the implications of AI tools used in early education, the nascent field of cancer neurotech, and the future of consumer wearable devices.

4 Sep 2026

Gut bacterial metabolite linked to inflammation in liver disease

Researchers have identified a link between specific activities in gut bacteria and the liver disease PSC.

4 Sep 2026

Gut bacterial molecule discovered to drive serious bile duct disease

Researchers at the University of Oslo and Oslo University Hospital have, together with international collaborators, discovered that a small molecule made exclusively by gut bacteria can actively drive disease in the bile ducts and worsen primary sclerosing cholangitis (PSC), a serious liver and bile duct disease.

4 Sep 2026

Pig kidney xenotransplantation offers a bridge for patients awaiting human donor kidneys

In January 2026, Tim Andrews, who had received a genetically edited pig kidney in January 2025, became the recipient of a human kidney.

3 Sep 2026

Cellular atlas offers clues to childhood Crohn’s treatment response

Researchers have created a detailed map of childhood Crohn's disease before and after treatment to help understand progression of the disease.

1 Sep 2026

Early-onset bowel cancer shows distinct biological and clinical features

One of Australia's largest real world studies of younger adults with advanced bowel cancer has identified important differences between cancers diagnosed before and after the age of 50, which could help doctors tailor treatments for younger adults more effectively.

1 Sep 2026

$15 million trial aims to improve treatment decisions for older AML patients

A newly funded national clinical trial initiative will gather critical evidence to determine the best treatment strategies for older adults with acute myeloid leukemia (AML), an aggressive, fast-moving blood cancer that leaves a substantial proportion of older patients facing uncertainty about whether to proceed to stem cell transplantation or continue non-transplant therapy.

27 Aug 2026

Study reveals how SGLT2 inhibitors improve failing heart function

Researchers have discovered that SGLT2 inhibitors, a class of drugs originally developed to treat diabetes and now widely used for heart failure, work by activating a key enzyme that helps heart cells produce and use energy more efficiently.

27 Aug 2026

Mayo Clinic joins multi-million dollar gene-editing project for children

Mayo Clinic is a clinical collaborator on an award of up to $27.7 million from the Advanced Research Projects Agency for Health (ARPA-H) to help develop affordable, scalable gene-editing therapies for children with rare inherited immune disorders.

27 Aug 2026

UofL receives new federal funding to advance metabolic health research

Chronic health conditions such as diabetes, obesity, heart disease and metabolic liver disease have sharply increased in recent decades and are among the most urgent health challenges facing our society.

27 Aug 2026

Mitochondrial transplantation helps repair donor organs during machine perfusion

Transplant medicine still depends on a limited supply of donor organs, while many retrieved grafts are discarded because ischemia, cold storage, and reperfusion can rapidly damage their cells.

25 Aug 2026

Combined bio-histological score prevents overtreatment in liver transplant patients

Long‑term outcomes after liver transplantation remain hampered by complications linked to intensive immunosuppression—infections, cardiovascular events, kidney dysfunction, and metabolic disorders affect 10% to 40% of recipients.

24 Aug 2026

Younger mismatched donors offer new hope for blood cancer patients

Blood cancer patients who cannot find a closely matched stem cell donor may have more transplant options than previously thought.

21 Aug 2026

Digital program reduces anxiety and depression in adults with chronic medical conditions

A digital program combining guided movement, breathing and meditation exercises, and coping-skills training reduced anxiety and depression symptoms in adults with chronic medical conditions, according to a new study published August 20th in the open access journal PLOS Medicine by Puneeta Tandon of the University of Alberta, Canada, and colleagues.

20 Aug 2026

Federal and industry sponsors play complementary roles in cancer clinical trials

A comparative study of the cancer clinical trial portfolios supported by federal funding versus industry funding reveals they have distinct, interdependent roles in cancer research.

20 Aug 2026

Scintica and Indus Instruments introduce PulSAR MD: An integrated M-Mode and Doppler data acquisition system with powerful automatic analysis

Scintica and Indus Instruments are proud to introduce PULSAR MD (Preclinical Ultrasound for Small Animal Research M-Mode and Doppler) system, the next evolution in preclinical hemodynamic assessment.

From Scintica Instrumentation Inc. 20 Aug 2026